Metabolic alkalosis in cystic fibrosis: from vascular volume depletion to impaired bicarbonate excretion.

Cystic fibrosis (CF) is the most common life-threatening genetic disease in the United States and among people of European descent. Despite the widespread distribution of the cystic fibrosis transmembrane conductance regulator (CFTR) along kidney tubules, specific renal phenotypes attributable to CF have not been well documented. Recent studies have demonstrated the downregulation of the apical Cl-/HCO3 - exchanger pendrin (Slc26a4) in kidney B-intercalated cells of CF mouse models. These studies have shown that kidneys of both mice and humans with CF have an impaired ability to excrete excess HCO3 -, thus developing metabolic alkalosis when subjected to excess HCO3 - intake. The purpose of this minireview is to discuss the latest advances on the role of pendrin as a molecule with dual critical roles in acid base regulation and systemic vascular volume homeostasis, specifically in CF. Given the immense prevalence of vascular volume depletion, which is primarily precipitated via enhanced chloride loss through perspiration, we suggest that the dominant presentation of metabolic alkalosis in CF is due to the impaired function of pendrin, which plays a critical role in systemic vascular volume and acid base homeostasis.

A safe and effective protocol for postdilution hemofiltration with regional citrate anticoagulation.

BACKGROUND: Regional citrate anticoagulation (RCA) is recommended during continuous renal replacement therapy. Compared to systemic anticoagulation, RCA provides a longer filter lifespan with the risk of metabolic alkalosis and impaired calcium homeostasis. Surprisingly, most RCA protocols are designed for continuous veno-venous hemodialysis or hemodiafiltration. Effective protocols for continuous veno-venous hemofiltration (CVVH) are rare, although CVVH is a standard treatment for high-molecular-weight clearance. Therefore, we evaluated a new RCA protocol for postdilution CVVH. METHODS: This is a monocentric prospective interventional study to evaluate a new RCA protocol for postdilution CVVH. We recruited surgical patients with stage III acute kidney injury who needed renal replacement therapy. We recorded dialysis and RCA data and hemodynamic and laboratory parameters during treatment sessions of 72 h. The primary endpoint was filter patency at 72 h. The major safety parameters were metabolic alkalosis and severe hypocalcemia at any time. RESULTS: We included 38 patients who underwent 66 treatment sessions. The mean filter lifespan was 66 ± 12 h, and 44 of 66 (66%) filters were patent at 72 h. After censoring for non-CVVH-related cessation of treatment, 83% of all filters were patent at 72 h. The delivered dialysis dose was 28 ± 5 ml/kgBW/h. The serum levels of creatinine, urea and beta2-microglobulin decreased significantly from day 0 to day 3. Metabolic alkalosis occurred in one patient. An iCa++ below 1.0 mmol/L occurred in four patients. Citrate accumulation did not occur. CONCLUSIONS: We describe a safe, effective, and easy-to-use RCA protocol for postdilution CVVH. This protocol provides a long and sustained filter lifespan without serious adverse effects. The risk of metabolic alkalosis and hypocalcemia is low. Using this protocol, a recommended dialysis dose can be safely administered with effective clearance of low- and middle-molecular-weight molecules. TRIAL REGISTRATION: The study was approved by the medical ethics committee of Heinrich-Heine University Duesseldorf (No. 2018-82KFogU). The trial was registered in the local study register of the university (No: 2018044660) on 07/04/2018 and was retrospectively registered at ClinicalTrials.gov (ClinicalTrials.gov Identifier: NCT03969966) on 31/05/2019.

Pulmonary artery air embolism with consequent primary respiratory alkalosis and secondary metabolic alkalosis following ventilation therapy: A case report.

BACKGROUND: An air embolism is a rare complication that occurs after air enters blood vessels, causing almost no to mild symptoms in patients. Although uncommon, air embolism can be deadly. Critical care professionals should know the warning signs of air embolism and be prepared to carry out the necessary therapeutic interventions. To reduce morbidity and death, this clinical condition must be identified early. Here we are presenting a case of pulmonary artery air embolism as a consequence of contrast agent injection in a chest computed tomography study. CASE PRESENTATION: A 70-year-old male patient were presented with pulmonary artery air embolism as a consequence of contrast agent injection in a chest computed tomography study. The patient experienced worsening respiratory symptoms that necessitated oxygen therapy, which resulted in respiratory alkalosis with secondary metabolic alkalosis. Following removal of the BiLevel positive airway pressure, the patient was switched to a 2-L nasal cannula, and his breathing rate increased to 34 breaths/min. After 8.5 hours of monitoring the patient's vital signs, the nasal cannula was removed, and the patient began breathing room air on his own. His vital signs then stabilized and arterial blood gas parameters returned to normal. The patient's condition improved, and he was discharged from the hospital after 9 days. Due to a high level of cytomegalovirus, the discharge prescriptions included valganciclovir film-coated tablets (900 mg, oral BID every 12 hours for 30 days) and apixaban (5 mg BID). The patient was then monitored at the outpatient clinic. CONCLUSION: Although rare, an air embolism can cause minor symptoms if it is small in volume or can be fatal if large. After contrast-enhanced radiological studies, physicians should be aware of any signs of respiratory distress or worsening of symptoms in their patients. Additionally, patients should be mindful of the potential complications associated with ventilation therapy.

[Two Cases of Pseudo-Bartter Syndrome in Childhood: When to Suspect a Rare Onset Pattern of Cystic Fibrosis].

Cystic fibrosis is a multisystem disease with extremely variable onset, symptoms and course. One of the onset modality but also a complication of the disease is the pseudo-Bartter syndrome, characterized by hyponatremia, hypochloremic dehydration and metabolic alkalosis in absence of any renal disease. This syndrome occurs more frequently in the first year of life and has a peak in the summer. In this article, we describe two cases of cystic fibrosis associated with pseudo-Bartter syndrome in childhood. Excluding every possible cause of metabolic alkalosis associated with hyponatremia was crucial for our diagnostic pathway, and the experience gained with the first case helped a lot with the second one.

Milk-Alkali Syndrome: A Century-old Cause of Hypercalcemia Requires the Addition of Venous Blood Gas in Hypercalcemia Workup.

The Milk-Alkali syndrome (MAS) is identified by the triad of high serum levels of calcium, metabolic alkalosis, and acute kidney injury, usually caused by consuming excessive amounts of calcium and absorbable alkali. If not treated promptly, the syndrome can result in rapid hypercalcemia, acute renal failure, and metastatic calcification. Notably, an increasing number of cases of MAS have been observed, potentially due to the rampant use of calcium-based over-the-counter supplements for the prevention and treatment of osteoporosis in postmenopausal women. Herein, we report a case of severe hypercalcemia due to prolonged intake of calcium carbonate supplements in the absence of any alkali. The case report highlights the importance of including venous blood gas (VBG) analysis as a part of the workup for hypercalcemia, as metabolic alkalosis can help clinch the diagnosis of MAS in the setting of severe hypercalcemia. How to cite this article: Sahu U, Trivedi T, Gupta R. Milk-Alkali Syndrome: A Century-old Cause of Hypercalcemia Requires the Addition of Venous Blood Gas in Hypercalcemia Workup. J Assoc Physicians India 2023;71(9):104-105.

Cloreto e status hidroeletrolítico e ácido-básico: importância clínica da determinação laboratorial / Chloride and hydroelectrolytic and acid base status: clinical importance of laboratorial determination

Apesar de o cloreto ser um exame amplamente disponível e solicitado em instituições de saúde, a maior pane dos médicos crê ser difícil interpretar seus resultados, estabelecer correlações com outros parâmetros laboratoriais associados e tomar decisões terapêuticas baseadas no mesmo. Devido à complexidade de sua homeostase e à intrincada correlação com o status hidroeletrolítico e ácido-básico, poucos médicos se sentem efetivamente aptos a aproveitar a valiosa informação clínica que ele pode revelar. Isto é agravado pela rarefeita bibliografia objetiva sobre o tema. Os autores desta revisão não foram capazes de encontrar nenhum capítulo especificamente dedicado ao cloreto nos principais livros-texto de Fisiologia, Clínica Médica e Nefrologia, disponíveis, à exceção de três revisões bibliográficas no Medline. Não obstante, tentamos organizar a informação tão claramente quanto possível, com o objetivo de tornar o cloreto uma ferramenta útil aos nossos colegas profissionais de saúde.

Even though chloride is a widely available and requested test in health institutions, most part of physicians find it difficult to interpret its results, establish correlations with other laboratory linked parameters and take therapeutic decisions based on it. Due to the complexity of its homeostatic balance and intrincated correlation to hydroelectrolytic and acid base status, few doctors feel actually able to fully profit from the valuable clinical information it can unfold. This is aggravated by the scarce objective bibliography on the issue. The authors of this review were not able to find any chapters specifically dedicated to chloride on major Physiology, Internal Medicine and Nephrology textbooks, but only three reviews on Medline. Nevertheless, we managed to organize the information as clearly as possible with the aim of making chloride test an useful tool to our fellow health professionals.

Síndromes de Bartter y Gitelman: revisión de los aspectos genéticos, fisiopatológicos y clínicos / Bartter and Gitelman syndromes: a review of genetic, physiopathological and clinical aspects

Los síndromes de Bartter y Gitelman son trastornos hereditarios caracterizados por una reducción marcada del transporte de sales por el asa ascendente gruesa de Henle. Los pacientes con el síndrome de Bartter presentan grandes pérdidas renales de agua, hipotensión arterial, alcalosis metabólica, hipokalemia e hipercalciuria y tienen un riesgo alto de sufrir nefrolitiasis. Estudios recientes han permitido subdividir el síndrome de Bartter en cinco tipos de acuerdo con el defecto genético y el fenotipo. El tipo 1 es causado por una mutación en el gen que codifica para el cotransportador cloro-sodio-potasio; el tipo 2 se debe a una mutación en el gen que codifica para el canal de potasio ROMK. Estas dos variantes genéticas se denominan conjuntamente síndrome de Bartter neonatal por el comienzo temprano de los síntomas, con polihidramnios materno, prematuridad, poliuria grave y nivel elevado de prostaglandina E2. El tipo 3, conocido como síndrome de Bartter clásico, es causado por mutaciones en el gen que codifica para el canal de cloro CLC-Kb; se detecta desde la niñez con retardo del crecimiento, poliuria, polidipsia y anorexia. El tipo 4 se asocia a sordera neurosensorial y se caracteriza por una mutación en el gen que codifica para la proteína Barttin la cual hace parte de los canales de cloro CLC-Kb y CLC-Ka; el tipo 5 se debe a una mutación en el gen que codifica para un receptor de calcio ubicado en la membrana basolateral del asa ascendente de Henle; estos pacientes, además de los síntomas comunes a los de otros tipos, presentan déficit de paratohormona. El síndrome de Gitelman tiene un fenotipo más leve y una presentación más tardía que el de Bartter; se diferencia de este porque los pacientes tienen hipomagnesemia e hipocalciuria; pueden ser asintomáticos o presentar debilidad muscular transitoria, parestesias, parálisis e incluso alteraciones del ritmo cardíaco. Los avances en genética molecular han permitido la clasificación adecuada de estos síndromes y han abierto puertas para diferentes opciones terapéuticas. Esta revisión incluye aspectos genéticos, fisiopatológicos y clínicos de estos síndromes.

Bartter and Gitelman syndromes are hereditary disorders characterized by a remarkable reduction of salt transportation by the thick ascending limb of the Henle‘s loop. Consequently, patients suffering from Bartter syndrome present with renal salt wasting, low blood pressure, hypokalemic metabolic alkalosis and hypercalciuria, and are at risk of developing renal stones. Based on recent studies, the Bartter syndrome has been subdivided into five types according to the genetic defect involved and the phenotype: type 1 is caused by a mutation in the gene coding for the chloride, sodium, and potassium co-transporter; type 2 is due to a mutation in the gene coding for the ROMK potassium channel. These two genetic variations are jointly denominated neonatal Bartter syndrome, because of their early clinical presentation, with maternal polyhydramnios, prematurity, severe polyuria and high levels of E2 prostaglandine. Type 3, also known as classic Bartter syndrome, is produced by mutations in the gen that codes for the chloride CLC-Kb channel; this type is detected since childhood with growth delay, polyuria, polydipsia and anorexia. Type 4, which is associated with neurosensorial deafness, is characterized by a mutation in the gen that codes for the Barttin protein which is a part of the CLC-Kb and CLC-Ka chloride channels. Type 5 appears because of a mutation in the gene that codes for a calcium receptor located at the basolateral membrane of the ascending limb of Henle‘s loop; patients with this type develop parathormone deficit, as well as the symptoms that are common to all types of the syndrome. The phenotype of Gitelman syndrome is less severe and its clinical presentation is delayed; it differs from the Bartter syndrome in that patients have hypomagnesemia and hipocalciuria. They may be asymptomatic or show transitory muscular weakness, paresthesias, paralysis and even cardiac rhythm alterations. Recent advances in molecular genetics have made it possible to distinguish between the different clinical types and are the basis for several therapeutic options. This review includes genetic, physiopathological and clinical aspects of the Bartter and Gitelman syndromes.

Relato de caso: aspectos clínicos e fisiopatológicos da síndrome de Gitelman - três casos / Relate the cases: clinical and pathofisiological aspects of Gitelman's et syndrome - three cases

As diferenças entre a síndrome de Gitelman e Síndromede Bartter têm sido bastante discutidas na literatua médica, tanto no que diz respeito aos recentes conhecimentos da área molecular e genética quanto aos aspectos laboratoriais. Säo apresentados os casos de três irmäos com alcolose metabóica hipocalêmica associada às alteraçöes clássicas da síndrome de Gitelman: hipomagnesemia e hipcalciúria. Os autores fazem uma revisäo de aspectos fisiopatológicos e terapêuticos das duas síndrome e sugerem a lembrança da síndrome de Gitelman no diagnóstico diferencial da hipocalemias

Alcalosis metabólica en fibrosis quística del páncreas / Metabolic alkalosis in cystic fibrosis of the pancreas

Un varón que había sufrido bronconeumonía 45 días después de nacer, ingresó al hospital a los 3 meses de edad por dificultad respiratoria, cianosis, deshidratación moderada, alcalosis metabólica, hiponatremia, hipocloremia, hipokalemia, excreción urinaria reducida de sodio y cloro y elevada de potasio. Sus funciones renales eran normales y en las radiografías de tórax se observaba evidencia de imágenes intersticiales de condensación y múltiples atelectasias segmentarias. La actividad de renina plasmática era de 30 ng/mL x h (n= 1 a 2,5 ng/mL x h) y la eliminación de cloro y sodio en el sudor estaban aumentadas a -x 62,6 y -x 83,9 mEq/L, respectivamente, respaldando el diagnóstico de fibrosis quística. La alcalosis metabólica es poco común. En ausencia de causas iatrogénicas debe sugerir hiperaldosteronismo, síndrome de Bartter y fibrosis quística

Tratamento dos desequilíbrios ácido-básicos no pós-operatório imediato em cirurgia cardíaca / Treatment of acid-base imbalance in the immediate postoperative period of cardiac surgery

Descreve-se, no pós-operatório imediato, em cirurgia cardíaca, as quatro principais alteraçöes do equilíbrio ácido-básico que podem ocorrer e analisa os mecanismos desencadeantes de cada uma delas, os mecanismos de tamponamento e de compensaçäo orgânica, apresentando esquemas ilustrativos. Ao tratar da causa de cada alteraçäo, mostra exemplos detalhados de sua casuística pessoal e discute o tratamento e a normalizaçäo laboratorial dos parâmetros que caracterizam o desequilíbrio. As medidas preventivas, os sinais e sintomas de cada uma delas säo descritos com pormenores. Quanto ao tratamento, cita os dois princípios fundamentais que o norteiam: o afastamento da causa determinante e a necessidade de repetiçäo das dosagens para avaliaçäo da tendência evolutiva do processo. Ao finalizar, faz referências às dificuldades de diagnóstico clínico devido a incidência concomitante de alteraçöes de causas primárias independentes e a inconstância de certos sinais e sintomas

Alcalose metabólica no pós-operatório de cirurgia cardíaca com circulaçäo extra-corpórea: influencia do emprego de soluçäo de Ringer-lactato e do sangue citratado / Metabolic alkalosis in the postoperative period of heart surgery with extracorporeal circulation: influence of the use of Ringer's lactate solution and citrate blood

Estudaram-se 40 pacientes submetidos à cirurgia cardíaca com circulaçäo extracorpórea (CEC), para correçäo de variadas afecçöes cardíacas. Neste estudo prospectivo, procurou-se analisar a alcalose metabólica (näo respiratória), quanto à sua importância, incidência e possíveis causas. Em relaçäo à etiologia, particular ênfase foi dada ao uso de soluçäo de Ringer-lactato no perfusato da CEC e à politransfusäo com sangue citratado. O emprego da soluçäo de Ringer-lactato näo foi responsável pelo aparecimento da alcalose metabólica, evidenciando-se em 7 casos (12,5%) a provável participaçäo etiológica do citrato empregado como anticoagulante de sangue transfundido